Skip to main content
OXFORD BIODYNAMICS PLC logo

OXFORD BIODYNAMICS PLC — Investor Relations & Filings

Ticker · OBD ISIN · GB00BD5H8572 LEI · 2138005Y1TK258O5U928 IL Professional, scientific and technical activities
Open in API
Filings indexed 416 across all filing types
Latest filing 2021-05-14 Remuneration Information
Country GB United Kingdom
Listing IL OBD

About OXFORD BIODYNAMICS PLC

https://www.oxfordbiodynamics.com/

Oxford BioDynamics PLC is a global biotechnology company advancing personalized healthcare by developing and commercializing precision medicine tests. The company's proprietary EpiSwitch® platform utilizes 3D genomics and epigenetic biomarkers to create diagnostic solutions for life-changing diseases, with a focus on oncology. Its portfolio of clinical tests includes the EpiSwitch® PSE, a blood test that assesses the likelihood of prostate cancer with high accuracy to help reduce unnecessary biopsies, and the EpiSwitch® CiRT, a test designed to predict a patient's therapeutic response to Immune Checkpoint Inhibitor cancer therapies. The platform enables the translation of 3D genome regulation into clinical applications for precision medicine at scale.

Recent filings

Filing Released Lang Actions
PDMR Dealing / Grant of Share Options
Remuneration Information Classification · 99% confidence The document is an RNS announcement (indicated by the RNS Number and the footer referencing RNS, the news service of the London Stock Exchange). The content explicitly details the 'Grant of Share Options' to directors and persons discharging managerial responsibilities (PDMRs), including specific details required under Article 19(3) of the EU Market Abuse Regulation. This type of filing, reporting personal share transactions or option grants by insiders, directly corresponds to the 'Director's Dealing' category. Although it is an RNS announcement, the specific nature of the content (PDMR Dealing) makes 'DIRS' a more precise classification than the general 'RNS' fallback.
2021-05-14 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 9346W' and contains the standard boilerplate text indicating it is provided by RNS, the news service of the London Stock Exchange. The content itself is a 'TR-1: Standard form for notification of major holdings,' detailing changes in voting rights by a shareholder (Jeremy Richard Chancellor Ironside). This type of regulatory filing concerning changes in significant share ownership thresholds directly maps to the 'Major Shareholding Notification' definition. Code Mapping: Major Shareholding Notification corresponds to code MRQ.
2021-04-28 English
Group of companies' accounts made up to 2020-09-30
Regulatory Filings
2021-04-21 English
New UK facilities to support expanded strategy
Regulatory Filings Classification · 100% confidence The document begins with 'RNS Number : 9085U' and contains information typical of a regulatory news service announcement, including a date (09 April 2021), company details, and contact information for investor relations. The content describes a business update: Oxford BioDynamics signing a lease for new facilities to support expanded strategy. Crucially, the footer explicitly states: 'This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.' and 'Reach announcements are identified with an orange label... so that they are distinguished from the RNS UK regulatory service.' Since this is a general business announcement distributed via the RNS/Reach system that does not fit into specific categories like Earnings Release (ER), Capital Update (CAP), or Director's Dealing (DIRS), the most appropriate fallback category for a general, non-core regulatory news item distributed through this channel is Regulatory Filings (RNS). It is not a Report Publication Announcement (RPA) because it is the substantive news itself, not just an announcement that a report is available.
2021-04-09 English
OBD signs agreement with Agilent Technologies
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 0865U' and contains information about a commercial agreement and product launch (EpiSwitch® Explorer Array Kit) by Oxford BioDynamics PLC, dated March 31, 2021. The text concludes with standard boilerplate language referencing RNS, the London Stock Exchange, and the Financial Conduct Authority, and ends with 'END'. This structure is characteristic of a regulatory news service announcement, which serves as a general disclosure mechanism for material, non-financial, or non-periodic information that doesn't fit a more specific SEC filing category (like 10-K or ER). Since it is a general announcement distributed via RNS and does not appear to be a full financial report (like 10-K or IR) or a specific announcement like a dividend (DIV) or director dealing (DIRS), the most appropriate classification is the general regulatory filing category.
2021-03-31 English
Result of AGM
AGM Information Classification · 99% confidence The document is an RNS announcement (indicated by 'RNS Number') dated March 24, 2021. The title explicitly states 'Results of Annual General Meeting'. The body confirms that 'all resolutions at the Company's Annual General Meeting, held earlier today, were duly passed.' This directly relates to the outcome of the AGM. While it reports the results, it is not the formal voting declaration (DVA) nor the proxy material (PSI). It is a direct announcement regarding the AGM proceedings, which fits best under the general AGM Information category (AGM-R), as it summarizes the outcome of that specific meeting.
2021-03-24 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.